JAMA Study Slaughters Antipsychotics For Kids, Teens Paradigm
Late yesterday I got a copy of the JAMA study detailing how kids and teens on atypical antipsychotics are putting on lots of weight very quickly and suffering detriments on just about every metabolic measure researchers looked at (my initial post is here). I’ll come to the study itself in a moment as well as the accompanying editorial, but first I wanted to note that I have been banging on the kids-on-meds issue (especially atypicals) for three years and have taken a ton of heat in the process. I feel vindicated by this new study and other recent studies tossing cold water on various treatment paradigms involving kids and many of you should feel vindicated as well. I remember how gingerly I first took on the subject in November 2006 and how many of you kicked me in the pants and told me to trust my instincts. Thanks.
Related posts:
- JAMA Study Finds Explosive Weight Gain In Kids On Antipsychotics
- Study: Medicaid Kids Get Antipsychotics At Four Times The Rate Of Privately-Insured Kids
- Questioning Antipsychotics In Kids, SF Chron Supports Their Use
- FDA Panel Recommends Approval Of Antipsychotics For Kids Aged 10, Older
- FDA Dubs Antipsychotics For Kids Effective With Substantial Risks